LMKC
CVS icon

L.M. Kohn & Company’s CVS Health CVS Stock Holding History

L.M. Kohn & Company’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$215K Sell
2,850
-1,378
-33% -$94.4K 0.26% 109
2025
Q2 		$292K Buy
4,228
+381
+10% +$25K 0.08% 208
2025
Q1 		$261K Sell
3,847
-2,050
-35% -$123K 0.07% 225
2024
Q4 		$265K Sell
5,897
-4,320
-42% -$242K 0.07% 208
2024
Q3 		$642K Sell
10,217
-3,451
-25% -$201K 0.16% 125
2024
Q2 		$807K Sell
13,668
-5,816
-30% -$364K 0.22% 97
2024
Q1 		$1.55M Sell
19,484
-689
-3% -$52.6K 0.44% 45
2023
Q4 		$1.59M Buy
20,173
+839
+4% +$59.7K 0.51% 40
2023
Q3 		$1.35M Sell
19,334
-132
-0.7% -$9.35K 0.49% 43
2023
Q2 		$1.35M Buy
19,466
+3,768
+24% +$268K 0.51% 46
2023
Q1 		$1.17M Buy
15,698
+39
+0.2% +$3.27K 0.48% 47
2022
Q4 		$1.46M Sell
15,659
-133
-0.8% -$12.8K 0.68% 28
2022
Q3 		$1.51M Sell
15,792
-1,816
-10% -$180K 0.74% 28
2022
Q2 		$1.63M Buy
17,608
+1,438
+9% +$140K 0.76% 27
2022
Q1 		$1.64M Buy
+16,170
New +$1.7M 0.63% 30

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

L.M. Kohn & Company's CVS Position: Q3 2025 in Review

L.M. Kohn & Company reduced its CVS Health (CVS) stake by 33% in Q3 2025, selling an estimated $94.4K and leaving 2,850 shares worth $215K. The position accounts for 0.26% of the portfolio, ranked #109.

L.M. Kohn & Company first reported a position in CVS in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.64M in Q1 2022. 1,837 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

  • L.M. Kohn & Company held 2,850 shares of CVS Health worth $215K as of Q3 2025.
  • L.M. Kohn & Company sold 1,378 CVS Health shares in Q3 2025, an estimated $94.4K.
  • CVS Health made up 0.26% of L.M. Kohn & Company's portfolio in Q3 2025, its #109 holding.
  • L.M. Kohn & Company first reported a position in CVS Health in Q1 2022 and has held it in 15 quarters since.
  • L.M. Kohn & Company's CVS Health position peaked at $1.64M in Q1 2022.
  • 1,837 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on L.M. Kohn & Company's 13F filing for Q3 2025, filed 4 Nov 2025.